Invention Grant
US09023833B2 Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds
有权
白蛋白，胆固醇和HDL水平高于最低阈值的患者的败血症的方法
- Patent Title: Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds
- Patent Title (中): 白蛋白，胆固醇和HDL水平高于最低阈值的患者的败血症的方法
-
Application No.: US13718246Application Date: 2012-12-18
-
Publication No.: US09023833B2Publication Date: 2015-05-05
- Inventor: Daniel M. Levine , Thomas S. Parker , Bruce R. Gordon , Stuart D. Saal
- Applicant: Daniel M. Levine , Thomas S. Parker , Bruce R. Gordon , Stuart D. Saal
- Applicant Address: US NY New York
- Assignee: Sepsicure, LLC
- Current Assignee: Sepsicure, LLC
- Current Assignee Address: US NY New York
- Agency: Abelman, Frayne & Schwab
- Main IPC: A61K31/685
- IPC: A61K31/685 ; A61K31/575 ; A61K31/23 ; A61K9/00 ; A61K9/107
Abstract:
The invention relates to a method for treating sepsis in subjects who exhibit serum albumin levels, and one of total cholesterol or HDL levels, above minimum threshold values. The method involves intravenous administration of an emulsion, which contains a phospholipid, a neutral lipid, and a cholate salt.
Public/Granted literature
- US20140171391A1 METHOD FOR TREATING SEPSIS IN PATIENTS WITH ALBUMIN, CHOLESTEROL AND HDL LEVELS ABOVE MINIMUM THRESHOLDS Public/Granted day:2014-06-19
Information query
